Fed. Circ. Affirms Stay Extension In Evista Dispute
The U.S. Court of Appeals for the Federal Circuit on Tuesday found that the lower court had not abused its discretion in granting Lilly's request to extend the stay after Teva submitted revisions to its proposed generic late in the litigation.
Teva first notified Lilly of its abbreviated new...
To view the full article, register now.